ESMO Breast 2026: BRCA Direct Pathways and the UK Retrospective Genetic Testing Program

At ESMO Breast 2026, Clare Turnbull, Professor of Translational Cancer Genetics at the Institute of Cancer Research, London, outlined the development of BRCA Direct pathways and focused on the UK Retrospective Genetic Testing Program. The presentation explores how high-throughput, clinician-led and patient-centred approaches may support broader access to germline genetic testing within the NHS.